Healthy Adults — Decision Making Study in Young and Middle-Aged Adults: Part II
Citation(s)
Ashby FG, Isen AM, Turken AU A neuropsychological theory of positive affect and its influence on cognition. Psychol Rev. 1999 Jul;106(3):529-50. Review.
Benton AL Development of a multilingual aphasia battery. Progress and problems. J Neurol Sci. 1969 Jul-Aug;9(1):39-48.
Braver TS, Barch DM A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev. 2002 Nov;26(7):809-17. Review.
Bryden PJ, Roy EA A new method of administering the Grooved Pegboard Test: performance as a function of handedness and sex. Brain Cogn. 2005 Aug;58(3):258-68.
Buckner RL Memory and executive function in aging and AD: multiple factors that cause decline and reserve factors that compensate. Neuron. 2004 Sep 30;44(1):195-208. Review.
Carstensen LL The influence of a sense of time on human development. Science. 2006 Jun 30;312(5782):1913-5.
Carver CS, White TL Behavioral Inhibition, Behavioral Activation, and Affective Responses to Impending Reward and Punishment: The BIS/BAS Scales. Journal of Personality and Social Psychology. 1994;67(2):319-33.
Charles ST, Carstensen LL Emotion regulation and aging. Gross JJ, editor. Handbook of Emotion Regulation. New York: Guilford Press; 2007. p. 307-20.
Christian BT, Narayanan TK, Shi B, Mukherjee J Quantitation of striatal and extrastriatal D-2 dopamine receptors using PET imaging of [(18)F]fallypride in nonhuman primates. Synapse. 2000 Oct;38(1):71-9.
Eppinger B, Hämmerer D, Li SC Neuromodulation of reward-based learning and decision making in human aging. Ann N Y Acad Sci. 2011 Oct;1235:1-17. doi: 10.1111/j.1749-6632.2011.06230.x. Review.
Hicks LH, Birren JE Aging, brain damage, and psychomotor slowing. Psychol Bull. 1970 Dec;74(6):377-96.
Kaasinen V, Rinne JO Functional imaging studies of dopamine system and cognition in normal aging and Parkinson's disease. Neurosci Biobehav Rev. 2002 Nov;26(7):785-93. Review.
Kessler RM Imaging methods for evaluating brain function in man. Neurobiol Aging. 2003 May-Jun;24 Suppl 1:S21-35; discussion S37-9. Review.
Knutson B, Samanez-Larkin GR, Kuhnen CM Gain and loss learning differentially contribute to life financial outcomes. PLoS One. 2011;6(9):e24390. doi: 10.1371/journal.pone.0024390. Epub 2011 Sep 6.
Li SC, Lindenberger U, Bäckman L Dopaminergic modulation of cognition across the life span. Neurosci Biobehav Rev. 2010 Apr;34(5):625-30. doi: 10.1016/j.neubiorev.2010.02.003. Epub 2010 Feb 10.
Li SC, Lindenberger U, Sikström S Aging cognition: from neuromodulation to representation. Trends Cogn Sci. 2001 Nov 1;5(11):479-486.
Lipkus IM, Samsa G, Rimer BK General performance on a numeracy scale among highly educated samples. Med Decis Making. 2001 Jan-Feb;21(1):37-44.
Luciana M, Depue RA, Arbisi P, Leon A Facilitation of working memory in humans by a d2 dopamine receptor agonist. J Cogn Neurosci. 1992 Winter;4(1):58-68. doi: 10.1162/jocn.1992.4.1.58.
MacPherson SE, Phillips LH, Della Sala S Age, executive function, and social decision making: a dorsolateral prefrontal theory of cognitive aging. Psychol Aging. 2002 Dec;17(4):598-609.
Mohr PN, Li SC, Heekeren HR Neuroeconomics and aging: neuromodulation of economic decision making in old age. Neurosci Biobehav Rev. 2010 Apr;34(5):678-88. doi: 10.1016/j.neubiorev.2009.05.010. Epub 2009 Jun 6. Review. Erratum in: Neurosci Biobehav Rev. 2012 Jan;36(1):735.
Moustafa AA, Cohen MX, Sherman SJ, Frank MJ A role for dopamine in temporal decision making and reward maximization in parkinsonism. J Neurosci. 2008 Nov 19;28(47):12294-304. doi: 10.1523/JNEUROSCI.3116-08.2008.
Platt ML, Huettel SA Risky business: the neuroeconomics of decision making under uncertainty. Nat Neurosci. 2008 Apr;11(4):398-403. doi: 10.1038/nn2062. Epub 2008 Mar 26. Review.
Raz N The Aging Brain Observed in Vivo: Differential Changes and Their Modifiers. Cabeza R, Nyberg L, Park D, editors. Cognitive neuroscience of aging: Linking cognitive and cerebral aging. Oxford University Press, New York, NY, US; 2005. p. 19-57.
Rogers R, Monsell S Costs of a predictible switch between simple cognitive tasks. Journal of experimental psychology: General. 1995;124(2):207-31.
Rubin DC Frontal-Striatal Circuits in Cognitive Aging: Evidence for Caudate Involvement. Aging, Neuropsychology, and Cognition. 1999;6(4):241-59.
Ruff RM, Parker SB Gender- and age-specific changes in motor speed and eye-hand coordination in adults: normative values for the Finger Tapping and Grooved Pegboard Tests. Percept Mot Skills. 1993 Jun;76(3 Pt 2):1219-30.
Salthouse TA What and When of Cognitive Aging. Current Directions in Psychological Science. 2004;13(4):140-4.
Samanez-Larkin GR, Carstensen LL Socioemotional Functioning and the Aging Brain. Decety J, Cacioppo JT, editors. The Handbook of Social Neuroscience. Oxford University Press; 2011. p. 507-21.
Servan-Schreiber D, Bruno RM, Carter CS, Cohen JD Dopamine and the mechanisms of cognition: Part I. A neural network model predicting dopamine effects on selective attention. Biol Psychiatry. 1998 May 15;43(10):713-22.
Stroop JE Studies of interference in serial verbal reactions. J Exp Psychol Gen. 1935;:18643-62.
Wardle MC, Treadway MT, Mayo LM, Zald DH, de Wit H Amping up effort: effects of d-amphetamine on human effort-based decision-making. J Neurosci. 2011 Nov 16;31(46):16597-602. doi: 10.1523/JNEUROSCI.4387-11.2011.
Watson D, Clark LA, Tellegen A Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988 Jun;54(6):1063-70.
Wechsler D Wechsler Adult Intelligence Scale, 3rd Edition. San Antonio, TX: Psychological Corporation; 1997.
Wechsler D Wechsler Memory Scale, 3rd edition. San Antonio, TX: Psychological Corporation; 1997.
West RL An application of prefrontal cortex function theory to cognitive aging. Psychol Bull. 1996 Sep;120(2):272-92. Review.
Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study. Neuroimage. 2009 May 15;46(1):31-8. doi: 10.1016/j.neuroimage.2009.01.049. Epub 2009 Feb 5. Erratum in: Neuroimage. 2009 Oct 1;47(4):2090.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.